Discontinued — last reported Q4 '22

Business Segments · Total Assets

Corporate And Other — Total Assets

Thermo Fisher Scientific Corporate And Other — Total Assets increased by 110.0% to $8.46B in Q4 2022 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2022
Rolls up toTotal Assets

How to read this metric

An increase may indicate higher centralized cash reserves or investments in shared corporate infrastructure, while a decrease might suggest asset divestitures or improved allocation of resources to operating segments.

Detailed definition

This metric represents the total value of assets held within the corporate or unallocated segment of the company. It typ...

Peer comparison

Peers often report this as 'Corporate and Other' or 'Unallocated' assets, which typically fluctuate based on corporate treasury activities and centralized real estate holdings.

Metric ID: tmo_segment_corporate_other_total_assets

Historical Data

2 periods
 Q4 '21Q4 '22
Value$4.03B$8.46B
QoQ Change+110.0%
YoY Change+110.0%
Range$4.03B$8.46B
Avg YoY Growth+110.0%
Median YoY Growth+110.0%

Frequently Asked Questions

What is Thermo Fisher Scientific's corporate and other — total assets?
Thermo Fisher Scientific (TMO) reported corporate and other — total assets of $8.46B in Q4 2022.
What does corporate and other — total assets mean?
The total value of assets held at the corporate level that are not assigned to any specific business segment.